Recent advances in spontaneous intracerebral hemorrhage

Ravi Garg, José Biller, Ravi Garg, José Biller

Abstract

Intracerebral hemorrhage (ICH) is a stroke subtype associated with significant morbidity and mortality. The purpose of this review is to provide an update on important research on ICH over the past three years. Topics covered include risk factors, imaging predictors of hematoma expansion, scoring schema to predict hematoma expansion, hemostatic therapies, acute blood pressure lowering, intraventricular administration of alteplase for intraventricular hemorrhage, and the current status of surgical therapies.

Keywords: antithrombotic reversal; blood pressure lowering; deompressive hemicraniectomy; hematoma expansion; intracerebral hemorrhage; intraventricular alteplase.

Conflict of interest statement

No competing interests were disclosed.No competing interests were disclosed.No competing interests were disclosed.No competing interests were disclosed.

Figures

Figure 1.. Intracerebral Hemorrhage due to arterial…
Figure 1.. Intracerebral Hemorrhage due to arterial hypertension.
(A) Hyper-attenuating hemorrhage visualized in the pons. (B) Hyper-attenuating hemorrhage centered in the left medial thalamus. Both locations are typical for hemorrhage related to long-standing hypertensive arteriopathy. These images constitute original, unpublished data obtained by the authors.
Figure 2.. Left putaminal hemorrhage with positive…
Figure 2.. Left putaminal hemorrhage with positive “black hole sign”.
A well-delineated margin is appreciated between the hypo-attenuating, round black hole and the hyper-attenuating hemorrhage. This image constitutes original, unpublished data obtained by the authors.
Figure 3.. Rivaroxaban-related intracerebral hemorrhage.
Figure 3.. Rivaroxaban-related intracerebral hemorrhage.
Hyper-attenuating hemorrhage is visualized in the left posterior temporal-parietal region with intraventricular extension. This image constitutes original, unpublished data obtained by the authors.

References

    1. An SJ, Kim TJ, Yoon BW: Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update. J Stroke. 2017;19(1):3–10. 10.5853/jos.2016.00864

    2. F1000 Recommendation

    1. Muntner P, Carey RM, Gidding S, et al. : Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline. Circulation. 2018;137(2):109–18. 10.1161/CIRCULATIONAHA.117.032582

    2. F1000 Recommendation

    1. Khan NI, Siddiqui FM, Goldstein JN, et al. : Association Between Previous Use of Antiplatelet Therapy and Intracerebral Hemorrhage Outcomes. Stroke. 2017;48(7):1810–7. 10.1161/STROKEAHA.117.016290

    2. F1000 Recommendation

    1. Renoux C, Vahey S, Dell’Aniello S, et al. : Association of Selective Serotonin Reuptake Inhibitors With the Risk for Spontaneous Intracranial Hemorrhage. JAMA Neurol. 2017;74(2):173–180. 10.1001/jamaneurol.2016.4529

    2. F1000 Recommendation

    1. Endres M, Nolte CH, Scheitz JF: Statin Treatment in Patients With Intracerebral Hemorrhage. Stroke. 2018;49(1):240–6. 10.1161/STROKEAHA.117.019322

    2. F1000 Recommendation

    1. Ziff OJ, Banerjee G, Ambler G, et al. : Statins and the risk of intracerebral haemorrhage in patients with stroke: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2019;90(1):75–83. 10.1136/jnnp-2018-318483

    2. F1000 Recommendation

    1. Wilson D, Ambler G, Shakeshaft C, et al. : Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study. Lancet Neurol. 2018;17(6):539–47. 10.1016/S1474-4422(18)30145-5

    2. F1000 Recommendation

    1. Holmes DR, Reddy VY, Turi ZG, et al. : Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374(9689):534–42. 10.1016/S0140-6736(09)61343-X

    2. F1000 Recommendation

    1. Charidimou A, Gang Q, Werring DJ: Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry. 2012;83(2):124–37. 10.1136/jnnp-2011-301308
    1. Rodrigues MA, Samarasekera N, Lerpiniere C, et al. : The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study. Lancet Neurol. 2018;17(3):232–40. 10.1016/S1474-4422(18)30006-1

    2. F1000 Recommendation

    1. Kuramatsu JB, Gerner ST, Schellinger PD, et al. : Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA. 2015;313(8):824–36. 10.1001/jama.2015.0846

    2. F1000 Recommendation

    1. Li Q, Zhang G, Xiong X, et al. : Black Hole Sign: Novel Imaging Marker That Predicts Hematoma Growth in Patients With Intracerebral Hemorrhage. Stroke. 2016;47(7):1777–81. 10.1161/STROKEAHA.116.013186

    2. F1000 Recommendation

    1. Demchuk AM, Dowlatshahi D, Rodriguez-Luna D, et al. : Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol. 2012;11(4):307–14. 10.1016/S1474-4422(12)70038-8

    2. F1000 Recommendation

    1. Dowlatshahi D, Brouwers HB, Demchuk AM, et al. : Predicting Intracerebral Hemorrhage Growth With the Spot Sign: The Effect of Onset-to-Scan Time. Stroke. 2016;47(3):695–700. 10.1161/STROKEAHA.115.012012

    2. F1000 Recommendation

    1. Al-Shahi Salman R, Frantzias J, Lee RJ, et al. : Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data. Lancet Neurol. 2018;17(10):885–94. 10.1016/S1474-4422(18)30253-9

    2. F1000 Recommendation

    1. Li Q, Zhang G, Huang YJ, et al. : Blend Sign on Computed Tomography: Novel and Reliable Predictor for Early Hematoma Growth in Patients With Intracerebral Hemorrhage. Stroke. 2015;46(8):2119–23. 10.1161/STROKEAHA.115.009185

    2. F1000 Recommendation

    1. Sporns PB, Schwake M, Schmidt R, et al. : Computed Tomographic Blend Sign Is Associated With Computed Tomographic Angiography Spot Sign and Predicts Secondary Neurological Deterioration After Intracerebral Hemorrhage. Stroke. 2017;48(1):131–5. 10.1161/STROKEAHA.116.014068

    2. F1000 Recommendation

    1. Morotti A, Dowlatshahi D, Boulouis G, et al. : Predicting Intracerebral Hemorrhage Expansion With Noncontrast Computed Tomography: The BAT Score. Stroke. 2018;49(5):1163–9. 10.1161/STROKEAHA.117.020138

    2. F1000 Recommendation

    1. Qureshi AI, Palesch YY, Barsan WG, et al. : Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. N Engl J Med. 2016;375(11):1033–43. 10.1056/NEJMoa1603460

    2. F1000 Recommendation

    1. Anderson CS, Heeley E, Huang Y, et al. : Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368(25):2355–65. 10.1056/NEJMoa1214609

    2. F1000 Recommendation

    1. Wang X, Arima H, Al-Shahi Salman R, et al. : Clinical prediction algorithm (BRAIN) to determine risk of hematoma growth in acute intracerebral hemorrhage. Stroke. 2015;46(2):376–81. 10.1161/STROKEAHA.114.006910
    1. Brouwers HB, Chang Y, Falcone GJ, et al. : Predicting hematoma expansion after primary intracerebral hemorrhage. JAMA Neurol. 2014;71(2):158–64. 10.1001/jamaneurol.2013.5433
    1. Mayer SA, Brun NC, Begtrup K, et al. : Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358(20):2127–37. 10.1056/NEJMoa0707534

    2. F1000 Recommendation

    1. Sprigg N, Flaherty K, Appleton JP, et al. : Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. Lancet. 2018;391(10135):2107–15. 10.1016/S0140-6736(18)31033-X

    2. F1000 Recommendation

    1. Frontera JA, Lewin JJ, 3rd, Rabinstein AA, et al. : Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: Executive Summary. A Statement for Healthcare Professionals From the Neurocritical Care Society and the Society of Critical Care Medicine. Crit Care Med. 2016;44(12):2251–7. 10.1097/CCM.0000000000002057

    2. F1000 Recommendation

    1. Baharoglu MI, Cordonnier C, Al-Shahi Salman R, et al. : Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet. 2016;387(10038):2605–13. 10.1016/S0140-6736(16)30392-0

    2. F1000 Recommendation

    1. Steiner T, Poli S, Griebe M, et al. : Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial. Lancet Neurol. 2016;15(6):566–73. 10.1016/S1474-4422(16)00110-1

    2. F1000 Recommendation

    1. Parry-Jones AR, Di Napoli M, Goldstein JN, et al. : Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhage. Ann Neurol. 2015;78(1):54–62. 10.1002/ana.24416

    2. F1000 Recommendation

    1. Granger CB, Alexander JH, McMurray JJ, et al. : Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981–92. 10.1056/NEJMoa1107039

    2. F1000 Recommendation

    1. Purrucker JC, Haas K, Rizos T, et al. : Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants. JAMA Neurol. 2016;73(2):169–77. 10.1001/jamaneurol.2015.3682

    2. F1000 Recommendation

    1. Pollack CV, Jr, Reilly PA, Eikelboom J, et al. : Idarucizumab for Dabigatran Reversal. N Engl J Med. 2015;373(6):511–20. 10.1056/NEJMoa1502000

    2. F1000 Recommendation

    1. Connolly SJ, Milling TJ, Jr, Eikelboom JW, et al. : Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors. N Engl J Med. 2016;375(12):1131–41. 10.1056/NEJMoa1607887

    2. F1000 Recommendation

    1. Ansell JE, Bakhru SH, Laulicht BE, et al. : Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban. Thromb Haemost. 2017;117(2):238–45. 10.1160/TH16-03-0224

    2. F1000 Recommendation

    1. Butcher KS, Jeerakathil T, Hill M, et al. : The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial. Stroke. 2013;44(3):620–6. 10.1161/STROKEAHA.111.000188

    2. F1000 Recommendation

    1. Morotti A, Brouwers HB, Romero JM, et al. : Intensive Blood Pressure Reduction and Spot Sign in Intracerebral Hemorrhage: A Secondary Analysis of a Randomized Clinical Trial. JAMA Neurol. 2017;74(8):950–60. 10.1001/jamaneurol.2017.1014

    2. F1000 Recommendation

    1. Morotti A, Boulouis G, Romero JM, et al. : Blood pressure reduction and noncontrast CT markers of intracerebral hemorrhage expansion. Neurology. 2017;89(6):548–54. 10.1212/WNL.0000000000004210

    2. F1000 Recommendation

    1. Kidwell CS, Rosand J, Norato G, et al. : Ischemic lesions, blood pressure dysregulation, and poor outcomes in intracerebral hemorrhage. Neurology. 2017;88(8):782–8. 10.1212/WNL.0000000000003630

    2. F1000 Recommendation

    1. Garg RK, Liebling SM, Maas MB, et al. : Blood pressure reduction, decreased diffusion on MRI, and outcomes after intracerebral hemorrhage. Stroke. 2012;43(1):67–71. 10.1161/STROKEAHA.111.629493
    1. Hanley DF, Lane K, McBee N, et al. : Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. Lancet. 2017;389(10069):603–11. 10.1016/S0140-6736(16)32410-2

    2. F1000 Recommendation

    1. Staykov D, Kuramatsu JB, Bardutzky J, et al. : Efficacy and safety of combined intraventricular fibrinolysis with lumbar drainage for prevention of permanent shunt dependency after intracerebral hemorrhage with severe ventricular involvement: A randomized trial and individual patient data meta-analysis. Ann Neurol. 2017;81(1):93–103. 10.1002/ana.24834

    2. F1000 Recommendation

    1. Esquenazi Y, Savitz SI, El Khoury R, et al. : Decompressive hemicraniectomy with or without clot evacuation for large spontaneous supratentorial intracerebral hemorrhages. Clin Neurol Neurosurg. 2015;128:117–22. 10.1016/j.clineuro.2014.11.015

    2. F1000 Recommendation

    1. Hanley DF, Thompson RE, Muschelli J, et al. : Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial. Lancet Neurol. 2016;15(12):1228–37. 10.1016/S1474-4422(16)30234-4

    2. F1000 Recommendation

    1. Hanley DF, Thompson RE, Rosenblum M, et al. : Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet. 2019;393(10175):1021–1032. 10.1016/S0140-6736(19)30195-3
    1. Scaggiante J, Zhang X, Mocco J, et al. : Minimally Invasive Surgery for Intracerebral Hemorrhage. Stroke. 2018;49(11):2612–20. 10.1161/STROKEAHA.118.020688

    2. F1000 Recommendation

    1. Morgenstern LB, Zahuranec DB, Sánchez BN, et al. : Full medical support for intracerebral hemorrhage. Neurology. 2015;84(17):1739–44. 10.1212/WNL.0000000000001525
    1. Sembill JA, Gerner ST, Volbers B, et al. : Severity assessment in maximally treated ICH patients: The max-ICH score. Neurology. 2017;89(5):423–31. 10.1212/WNL.0000000000004174

    2. F1000 Recommendation

    1. Zhou Y, Wang Y, Wang J, et al. : Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation. Prog Neurobiol. 2014;115:25–44. 10.1016/j.pneurobio.2013.11.003
    1. Volbers B, Giede-Jeppe A, Gerner ST, et al. : Peak perihemorrhagic edema correlates with functional outcome in intracerebral hemorrhage. Neurology. 2018;90(12):e1005–e1012. 10.1212/WNL.0000000000005167
    1. Kim H, Edwards NJ, Choi HA, et al. : Treatment Strategies to Attenuate Perihematomal Edema in Patients With Intracerebral Hemorrhage. World Neurosurg. 2016;94:32–41. 10.1016/j.wneu.2016.06.093

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel